or Try an Advanced Search...

    Anti Diabetic Drugs Stocks List

    Symbol Grade Name % Change
    NVO A Novo Nordisk A/S 1.88
    TERN B Terns Pharmaceuticals, Inc. 0.59
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biopharmaceutical Obesity Peptide Hormones Bile Acid Chronic Liver Diseases Diabetes Diabetes Care Endocrine System Glucagon Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hepatitis Hormone Therapy Hormones IBD 50 Inflammation Insulin Life Sciences

    Related ETFs - A few ETFs which own one or more of the above listed Anti Diabetic Drugs stocks.

    Symbol Grade Name Weight
    EDEN A iShares MSCI Denmark Capped ETF 24.13
    OZEM A Roundhill GLP-1 & Weight Loss ETF 23.84
    THNR A Amplify Weight Loss Drug & Treatment ETF 14.9
    PPH A Market Vectors Pharmaceutical ETF 10.11
    IGTR A Innovator Gradient Tactical Rotation Strategy ETF 8.71
    View all Anti Diabetic Drugs ETFs...
    Compare ETFs
    Compare EDEN to IGTR Compare OZEM to THNR Compare PPH to IGTR

        Anti Diabetic Drugs Stocks Recent News

        Date Stock Title
        Jun 30 NVO Surprise! Novo Nordisk's Wegovy Just Achieved Another Milestone. Here's What You Need to Know.
        Jun 29 NVO The Top Country With Most Scientists per Capita in the World
        Jun 29 NVO If These 3 Words Are True, Altimmune's Weight Loss Candidate Could Beat Novo Nordisk's Wegovy
        Jun 28 NVO Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
        Jun 27 NVO Novo Nordisk (NVO) Rises Higher Than Market: Key Facts
        Jun 27 NVO Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
        Jun 27 NVO 2seventy bio completes $40m haemophilia A program deal with Novo Nordisk
        Jun 27 NVO Novo Nordisk To Restrict Initial Wegovy Sales In China Amid High Demand
        Jun 27 NVO European Equities Close Mostly Lower Thursday; Bank of England Warns of 'Sharp Correction' Risk
        Jun 27 NVO Top Midday Stories: Walgreens Shares Tumble on Lower Guidance, Store Closures; SM Energy, NOG to Buy XCL Resources; Uber, Lyft Worker Classification Heads to Massachusetts Ballot
        Jun 27 NVO Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
        Jun 27 NVO Walgreens cuts EPS guidance, plans to close more stores
        Jun 27 NVO Novo Nordisk's (NVO) Hypertension Drug Study Fails to Meet Goal
        Jun 27 NVO Market Chatter: Novo Nordisk to Limit Launch of Wegovy in China, Executive Says
        Jun 27 NVO 2seventy slims down with sale of hemophilia assets to Novo
        Jun 27 NVO Novo reportedly eyeing a limited launch of Wegovy in China
        Jun 27 NVO Novo Nordisk buys 2seventy bio’s Hemophilia A program
        Jun 27 NVO Novo Nordisk’s ocedurenone Phase III flop costs company $816m
        Jun 27 NVO Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
        Jun 27 NVO Bernie Sanders: 'Ozempic Will Likely Become One Of The Best-Selling Pharmaceutical Products In History' — Americans Shouldn't Pay 10-15X More
        Related Industries: Biotechnology
        Related Stock Lists: Biopharmaceutical Obesity Peptide Hormones Bile Acid Chronic Liver Diseases Diabetes Diabetes Care Endocrine System Glucagon Glucagon Like Peptide 1 Growth Hormone Growth Hormone Therapy Haemophilia Hepatitis Hormone Therapy Hormones IBD 50 Inflammation Insulin Life Sciences
        Anti Diabetic Drugs

        Anti-diabetic drugs are medications used to treat people with diabetes mellitus. They work by either increasing the amount of insulin produced by the body, or by helping the body use the insulin it produces more effectively. Common types of anti-diabetic drugs include insulin, sulfonylureas, biguanides, thiazolidinediones, meglitinides, and alpha-glucosidase inhibitors.

        Browse All Tags